Evaluating the safety and usability of BALT medical devices for various brain and vascular conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect clinical data on the safety, performance, and usability of BALT medical devices used in treating conditions such as intracranial aneurysms and acute ischemic strokes. The study utilizes an electronic platform for post-marketing clinical follow-up, allowing for continuous data collection without a hierarchical order of objectives. Participants will provide informed consent to be part of this exploratory initiative, which focuses on real-world outcomes associated with the use of these devices.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Provision of a signed, written and dated informed consent or non-opposition (where applicable)

Exclusion Criteria

* Device(s) used in multiple procedures (two, or more, pathologies treated during the same procedure)
* Contra-indications of each device as described in the instructions for use.

Where it's running

• CHU Angers
  Angers, France Recruiting
• Chu Bordeaux
  Bordeaux, France Recruiting
• CHU Grenoble Alpes
  La Tronche, France Recruiting
• Hôpital Roger Salengro
  Lille, France Recruiting
• Kremlin Bicêtre - APHP
  Paris, France Recruiting
• Chu Tours
  Tours, France Recruiting

Study contacts

• Study coordinator: Clinical Affairs Department
• Email: Evidence@baltgroup.com
• Phone: +33 1 39 89 46 41

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collecting real-life data on endovascular treatments for brain aneurysms

  This study is collecting real-life information on how safe and effective a specific type of device is for treating brain aneurysms in patients.

  Recruiting Microvention-Terumo, Inc. · Vigo, Pontevedra · NCT06494436

• Short-Term outside-in nerve stimulation for acute ischemic stroke

  This trial tests whether a 5-day external trigeminal nerve stimulation given after stroke can help more patients recover better than a sham treatment.

  Recruiting Xidian University · Xi'an · NCT07911605

• Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal

  This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.

  Recruiting Phase 3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Barcelona · NCT07902791

• Safety of adding NRICM301 to standard care for adults with acute ischemic stroke

  This study tests whether adding NRICM301, a traditional Chinese medicine formula, to usual care is safe for adults with acute ischemic stroke.

  Recruiting En Chu Kong Hospital · New Taipei City · NCT07900503

• Intracranial Recanalization with LT3001 in Acute Ischemic Stroke

  This phase II study tests whether LT3001 given to adults with acute ischemic stroke can help reopen blocked brain arteries.

  Recruiting Phase 2 Lumosa Therapeutics Co., Ltd. · Taichung · NCT07890298

• Mobilisation After Endovascular Stroke Treatment

  This study checks whether moving around 12 hours after endovascular stroke treatment is as safe as moving around 24 hours for people with an acute ischemic stroke.

  Recruiting at 2 sites Karolinska Institutet · Tampere and 1 other locations · NCT07860333

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.